165 related articles for article (PubMed ID: 14604779)
1. Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
Okamura N; Hashimoto K; Shimizu E; Koike K; Ohgake S; Koizumi H; Kumakiri C; Komatsu N; Iyo M
Brain Res; 2003 Nov; 992(1):114-9. PubMed ID: 14604779
[TBL] [Abstract][Full Text] [Related]
2. The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis.
Carter K; Dickerson J; Schoepp DD; Reilly M; Herring N; Williams J; Sallee FR; Sharp JW; Sharp FR
Neuropharmacology; 2004 Dec; 47(8):1135-45. PubMed ID: 15567423
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A1 receptor agonists block the neuropathological changes in rat retrosplenial cortex after administration of the NMDA receptor antagonist dizocilpine.
Okamura N; Hashimoto K; Shimizu E; Kumakiri C; Komatsu N; Iyo M
Neuropsychopharmacology; 2004 Mar; 29(3):544-50. PubMed ID: 14603270
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
Okamura N; Hashimoto K; Kanahara N; Shimizu E; Kumakiri C; Komatsu N; Iyo M
Eur J Pharmacol; 2003 Feb; 461(2-3):93-8. PubMed ID: 12586203
[TBL] [Abstract][Full Text] [Related]
5. Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.
Hashimoto K; Tomitaka S; Bi Y; Narita N; Minabe Y; Iyo M
Eur J Neurosci; 1997 Sep; 9(9):1891-901. PubMed ID: 9383212
[TBL] [Abstract][Full Text] [Related]
6. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA
Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973
[TBL] [Abstract][Full Text] [Related]
7. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
[TBL] [Abstract][Full Text] [Related]
8. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
[TBL] [Abstract][Full Text] [Related]
9. Effects of age and gender on the expression of brain-derived neurotrophic factor mRNA in rat retrosplenial cortex following administration of dizocilpine.
Matsuki H; Shirayama Y; Hashimoto K; Tanaka A; Minabe Y
Neuropsychopharmacology; 2001 Aug; 25(2):258-66. PubMed ID: 11425509
[TBL] [Abstract][Full Text] [Related]
10. Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex.
Tomitaka S; Tomitaka M; Tolliver BK; Sharp FR
Eur J Neurosci; 2000 Apr; 12(4):1420-30. PubMed ID: 10762370
[TBL] [Abstract][Full Text] [Related]
11. The mGluR
Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
[TBL] [Abstract][Full Text] [Related]
12. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.
Bond A; Jones NM; Hicks CA; Whiffin GM; Ward MA; O'Neill MF; Kingston AE; Monn JA; Ornstein PL; Schoepp DD; Lodge D; O'Neill MJ
J Pharmacol Exp Ther; 2000 Sep; 294(3):800-9. PubMed ID: 10945827
[TBL] [Abstract][Full Text] [Related]
14. Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine.
Tian Z; Dong C; Fujita A; Fujita Y; Hashimoto K
Pharmacol Biochem Behav; 2018 Sep; 172():17-21. PubMed ID: 30030125
[TBL] [Abstract][Full Text] [Related]
15. Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist.
Cai Z; Xiao F; Fratkin JD; Rhodes PG
Neuroreport; 1999 Dec; 10(18):3927-31. PubMed ID: 10716235
[TBL] [Abstract][Full Text] [Related]
16. Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.
Johnson MP; Chamberlain M
Neuropharmacology; 2002 Oct; 43(5):799-808. PubMed ID: 12384165
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268.
Sutton LP; Rushlow WJ
J Neurochem; 2011 Jun; 117(6):973-83. PubMed ID: 21477044
[TBL] [Abstract][Full Text] [Related]
18. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
Greenslade RG; Mitchell SN
Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
[TBL] [Abstract][Full Text] [Related]
19. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
Hiyoshi T; Kambe D; Karasawa J; Chaki S
Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels.
Lorrain DS; Baccei CS; Correa LD; Bristow LJ
Neuropharmacology; 2005 Jun; 48(7):927-35. PubMed ID: 15857619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
